Regeneron Pharmaceuticals (REGN) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free REGN Stock Alerts $937.61 +34.13 (+3.78%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Regeneron Pharmaceuticals Short Interest DataCurrent Short Volume1,390,000 sharesPrevious Short Volume1,420,000 sharesChange Vs. Previous Month-2.11%Dollar Volume Sold Short$1.25 billionShort Interest Ratio / Days to Cover3.0Last Record DateApril 15, 2024Outstanding Shares109,760,000 sharesPercentage of Shares Shorted1.27%Today's Trading Volume1,066,779 sharesAverage Trading Volume499,355 sharesToday's Volume Vs. Average214% Short Selling Regeneron Pharmaceuticals ? Sign up to receive the latest short interest report for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatREGN Short Interest Over TimeREGN Days to Cover Over TimeREGN Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Regeneron Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,390,000 shares $1.25 billion -2.1%N/A3 $898.56 3/31/20241,420,000 shares $1.37 billion +2.2%N/A3 $962.49 3/15/20241,390,000 shares $1.34 billion +2.2%N/A2.7 $964.47 2/29/20241,360,000 shares $1.31 billion -0.7%N/A2.4 $966.09 2/15/20241,370,000 shares $1.31 billion +9.6%N/A2.4 $954.73 1/31/20241,250,000 shares $1.18 billion +16.8%N/A2.2 $942.78 Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,070,000 shares $998.52 million +0.9%1.0%1.9 $933.20 12/31/20231,060,000 shares $930.99 million -13.1%1.0%2 $878.29 12/15/20231,220,000 shares $1.05 billion -0.8%1.2%2.4 $859.14 11/30/20231,230,000 shares $1.01 billion -12.1%1.2%2.7 $823.81 11/15/20231,400,000 shares $1.11 billion +6.9%1.3%3.3 $792.38 10/31/20231,310,000 shares $1.02 billion -4.4%1.3%3 $779.89 10/15/20231,370,000 shares $1.15 billion +16.1%1.3%3 $839.63 9/30/20231,180,000 shares $971.09 million -18.6%1.1%2.4 $822.96 9/15/20231,450,000 shares $1.19 billion -2.0%1.4%2.5 $823.40 8/31/20231,480,000 shares $1.22 billion +8.8%1.4%2.5 $826.49 8/15/20231,360,000 shares $1.10 billion +1.5%1.3%2.1 $805.91 7/31/20231,340,000 shares $994.16 million +5.5%1.3%2.1 $741.91 7/15/20231,270,000 shares $912.52 million +17.6%N/A2 $718.52 6/30/20231,080,000 shares $776.02 million -12.2%N/A1.8 $718.54 6/15/20231,230,000 shares $963.18 million +7.9%N/A2.2 $783.07 5/31/20231,140,000 shares $838.54 million -5.8%N/A2 $735.56 5/15/20231,210,000 shares $908.66 million +2.5%N/A2.1 $750.96 4/30/20231,180,000 shares $946.11 million -2.5%1.1%2 $801.79 4/15/20231,210,000 shares $1.00 billion -6.9%1.2%2 $829.33 3/31/20231,300,000 shares $1.07 billion +7.4%1.2%2 $821.67 3/15/20231,210,000 shares $919.96 million +0.8%1.2%1.9 $760.30 2/28/20231,200,000 shares $912.50 million -10.5%1.2%1.9 $760.42 2/15/20231,340,000 shares $1.01 billion -8.2%1.3%2.1 $752.40 1/31/20231,460,000 shares $1.11 billion +3.6%1.4%2.2 $758.47 1/15/20231,410,000 shares $1.02 billion -6.0%1.4%2.2 $722.13 12/30/20221,500,000 shares $1.08 billion +4.2%1.5%2.2 $721.49 12/15/20221,440,000 shares $1.05 billion -7.1%1.4%2.1 $731.27 11/30/20221,550,000 shares $1.17 billion -11.9%1.5%2.1 $751.70 11/15/20221,760,000 shares $1.28 billion -0.6%1.7%2.3 $728.73 10/31/20221,770,000 shares $1.33 billion -16.1%1.7%2.3 $748.75 10/15/20222,110,000 shares $1.55 billion -7.5%2.1%2.8 $736.06 9/30/20222,280,000 shares $1.57 billion -3.8%2.2%3.2 $688.87 9/15/20222,370,000 shares $1.67 billion -18.6%2.3%3.5 $705.85 8/31/20222,910,000 shares $1.69 billion -0.7%2.8%4.3 $581.06Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here REGN Short Interest - Frequently Asked Questions What is Regeneron Pharmaceuticals' current short interest? Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,390,000 shares of REGN short. Learn More on Regeneron Pharmaceuticals' current short interest. What is a good short interest ratio for Regeneron Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REGN shares currently have a short interest ratio of 3.0. Learn More on Regeneron Pharmaceuticals's short interest ratio. Which institutional investors are shorting Regeneron Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: Capstone Investment Advisors LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, Covenant Asset Management LLC, Nomura Holdings Inc., Readystate Asset Management LP, Citadel Advisors LLC, Cubist Systematic Strategies LLC, Eisler Capital UK Ltd., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, Wells Fargo & Company MN, UBS Group AG, BNP Paribas Financial Markets, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Regeneron Pharmaceuticals' short interest increasing or decreasing? Regeneron Pharmaceuticals saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 1,390,000 shares, a decline of 2.1% from the previous total of 1,420,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Regeneron Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies compare to Regeneron Pharmaceuticals: Vertex Pharmaceuticals Incorporated (1.56%), Bristol-Myers Squibb (1.69%), GSK plc (0.36%), Sanofi (0.13%), Zoetis Inc. (0.70%), Pfizer Inc. (1.20%), Takeda Pharmaceutical Company Limited (0.19%), Royalty Pharma plc (3.74%), BeiGene, Ltd. (1.92%), Catalent, Inc. (3.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Regeneron Pharmaceuticals stock? Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. REGN shares are trading up $34.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Regeneron Pharmaceuticals? A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further. How often is Regeneron Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VRTX Short Interest Data BMY Short Interest Data GSK Short Interest Data SNY Short Interest Data ZTS Short Interest Data PFE Short Interest Data TAK Short Interest Data RPRX Short Interest Data BGNE Short Interest Data CTLT Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REGN) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetry$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTracker